Kobayashi Tatsuya
Nagoya Radiosurgery Center, Nagoya Kyoritsu Hospital, Nagoya, Japan.
Prog Neurol Surg. 2009;22:63-76. doi: 10.1159/000163383.
A new treatment strategy using the gamma knife is proposed, based on evaluation of long-term results of gamma knife radiosurgery for residual or recurrent craniopharyngioma after microsurgery. A total of 98 of 107 patients were followed up for a mean of 65.5 months after radiosurgery. The mean volume of tumor was 3.5 ml. Tumors were treated with a marginal dose of 11.5 Gy using a mean of 4.5 isocenters. Final overall results: complete response 19.4%, partial response 67.4%, tumor control rate 79.6% and progression rate 20.4%. Age (for adults) and nature of tumor (cystic or mixed) were statistically significantly favorable and unfavorable prognostic factors, respectively. Patient outcome was excellent in 45 cases, good in 23, fair in 4 and poor in 3. Sixteen patients died and deterioration of visual and endocrinological functions were found as side effects in 6 patients (6.1%). The strategy is for a small tumor between the retrochiasm and anterior stalk to be treated by gamma knife radiotherapy with 10-12 Gy, allowing cure without neuroendocrine deficits.
基于对显微手术后残留或复发颅咽管瘤进行伽玛刀放射外科治疗的长期结果评估,提出了一种使用伽玛刀的新治疗策略。107例患者中的98例在放射外科治疗后平均随访65.5个月。肿瘤平均体积为3.5毫升。使用平均4.5个等中心,以11.5 Gy的边缘剂量治疗肿瘤。最终总体结果:完全缓解率为19.4%,部分缓解率为67.4%,肿瘤控制率为79.6%,进展率为20.4%。年龄(成人)和肿瘤性质(囊性或混合性)分别是具有统计学意义的有利和不利预后因素。45例患者预后极佳,23例良好,4例尚可,3例较差。16例患者死亡,6例患者(6.1%)出现视力和内分泌功能恶化的副作用。该策略是对位于视交叉后和垂体柄前方的小肿瘤采用10 - 12 Gy的伽玛刀放射治疗,有望实现治愈且无神经内分泌缺陷。